191 related articles for article (PubMed ID: 861349)
1. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
Calmettes C; Moudktar MS; Milhaud G
Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
[TBL] [Abstract][Full Text] [Related]
2. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
4. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
Diez JJ; Iglesias P
Thyroid; 2004 Nov; 14(11):984-5. PubMed ID: 15678599
[No Abstract] [Full Text] [Related]
5. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
Calmettes C; Moukhtar MS; Milhaud G
Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
[TBL] [Abstract][Full Text] [Related]
6. [Use of tumor markers in monitoring thyroid carcinoma].
Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
[TBL] [Abstract][Full Text] [Related]
7. [Screening for the familial form of medullary cancer of the thyroid].
Allannic H
Bull Cancer; 1984; 71(2):125-9. PubMed ID: 6733292
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
9. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
[TBL] [Abstract][Full Text] [Related]
10. Localization and resection of clinically inapparent medullary carcinoma of the thyroid.
Norton JA; Doppman JL; Brennan MF
Surgery; 1980 Jun; 87(6):616-22. PubMed ID: 7376073
[TBL] [Abstract][Full Text] [Related]
11. The use of octreotide in the treatment of medullary thyroid carcinoma.
Frank-Raue K; Ziegler R; Raue F
Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
Surg Forum; 1979; 30():120-1. PubMed ID: 395674
[No Abstract] [Full Text] [Related]
14. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
Linehan WM; Farrell RE; Cooper CW; Wells SA
Surg Forum; 1977; 28():110-2. PubMed ID: 617389
[No Abstract] [Full Text] [Related]
15. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
[TBL] [Abstract][Full Text] [Related]
17. [Tumor markers in C-cell cancer].
Raue F; Schmidt-Gayk H; Ziegler R
Dtsch Med Wochenschr; 1983 Feb; 108(8):283-7. PubMed ID: 6297868
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of thallium-201 in medullary thyroid cancer with negative serum calcitonin and carcinoembryonic antigens: a case report.
Koizumi M; Watari T; Hirabayashi K
Ann Nucl Med; 1993 Feb; 7(1):53-6. PubMed ID: 8461239
[TBL] [Abstract][Full Text] [Related]
19. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors.
Pichon MF; Coquin G; Fauveau C; Rey A
Anticancer Res; 1999; 19(2B):1445-50. PubMed ID: 10365121
[TBL] [Abstract][Full Text] [Related]
20. [Value of the assay of plasma carcinoembryonic antigen and thyrocalcitonin in the detection of medullary cancer of the thyroid with amyloid stroma. Results of a familial survey of 47 subjects].
Allanic H
Ann Med Interne (Paris); 1984; 135(5):341-4. PubMed ID: 6486613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
